Skip to main content
SpringerLink
Log in

Management of metastatic melanoma patients with brain metastases

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Brain metastases seem to be an almost inevitable complication in patients with metastatic melanoma. Except for the rare patients who can undergo successful surgical resection of brain metastases, current management strategies do not appear adequate and result in a poor outcome (median survival, 2–4 months). In recent small series, stereotactic radiosurgery or gamma-knife treatment has suggested improvement in local control compared with whole brain radiation therapy. We have recently shown prolonged survival (11.1 months) using a multimodality treatment approach in 44 sequential patients with melanoma brain metastases. A subsequent study demonstrated that the outcome of biochemotherapy for metastatic melanoma is not affected by the presence or absence of brain metastases. Our results suggest that the outcome of patients with melanoma brain metastases can be improved using a multidisciplinary management strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Davey P: Brain metastases. Curr Probl Cancer 1999, 23:59–98.

    Article  PubMed  CAS  Google Scholar 

  2. Wen PY, Loeffler JS: Management of brain metastases. Oncology (Williston Park) 1999, 13:941–954, 957–961; discussion 961–942, 949.

    CAS  Google Scholar 

  3. Davey P: Brain metastases: treatment options to improve outcomes. CNS Drugs 2002, 16:325–338.

    Article  PubMed  CAS  Google Scholar 

  4. Harrison BE, Johnson JL, Clough RW, Halperin EC: Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 2003, 26:354–357.

    Article  PubMed  Google Scholar 

  5. Hall WA, Djalilian HR, Nussbaum ES, Cho KH: Long-term survival with metastatic cancer to the brain. Med Oncol 2000, 17:279–286.

    PubMed  CAS  Google Scholar 

  6. Gaspar L, Scott C, Rotman M, et al.: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745–751.

    Article  PubMed  CAS  Google Scholar 

  7. Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.

    Article  PubMed  CAS  Google Scholar 

  8. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583–590.

    Article  PubMed  CAS  Google Scholar 

  9. Mintz AH, Kestle J, Rathbone MP, et al.: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470–1476.

    Article  PubMed  CAS  Google Scholar 

  10. Brega K, Robinson WA, Winston K, Wittenberg W: Surgical treatment of brain metastases in malignant melanoma. Cancer 1990, 66:2105–2110.

    Article  PubMed  CAS  Google Scholar 

  11. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF: Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998, 88:11–20.

    PubMed  CAS  Google Scholar 

  12. Wronski M, Arbit E, Burt M, et al.: Resection of brain metastases from sarcoma. Ann Surg Oncol 1995, 2:392–399.

    Article  PubMed  CAS  Google Scholar 

  13. Hagen NA, Cirrincione C, Thaler HT, DeAngelis LM: The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990, 40:158–160.

    PubMed  CAS  Google Scholar 

  14. Skibber JM, Soong SJ, Austin L, et al.: Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996, 3:118–123.

    Article  PubMed  CAS  Google Scholar 

  15. Nieder C, Schwerdtfeger K, Steudel WI, Schnabel K: Patterns of relapse and late toxicity after resection and whole-brain radiotherapy for solitary brain metastases. Strahlenther Onkol 1998, 174:275–278.

    PubMed  CAS  Google Scholar 

  16. van den Bent MJ: Management of metastatic (parenchymal, leptomeningeal, and epidural) lesions. Curr Opin Oncol 2004, 16:309–313.

    Article  PubMed  Google Scholar 

  17. Fife KM, Colman MH, Stevens GN, et al.: Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004, 22:1293–1300.

    Article  PubMed  CAS  Google Scholar 

  18. Lagerwaard FJ, Levendag PC, Nowak PJ, et al.: Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43:795–803.

    Article  PubMed  CAS  Google Scholar 

  19. Broadbent AM, Hruby G, Tin MM, et al.: Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 2004, 71:259–265.

    Article  PubMed  Google Scholar 

  20. Meier S, Baumert BG, Maier T, et al.: Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004, 27:145–149.

    Article  PubMed  CAS  Google Scholar 

  21. Overgaard J: Radiation treatment of malignant melanoma. Int J Radiat Oncol Biol Phys 1980, 6:41–44.

    PubMed  CAS  Google Scholar 

  22. Strauss A, Dritschilo A, Nathanson L, Piro AJ: Radiation therapy of malignant melanomas: an evaluation of clinically used fractionation schemes. Cancer 1981, 47:1262–1266.

    Article  PubMed  CAS  Google Scholar 

  23. Adam JS, Habeshaw T, Kirk J: Response rate of malignant melanoma to large fraction irradiation. Br J Radiol 1982, 55:605–607.

    Article  PubMed  CAS  Google Scholar 

  24. Doss LL, Memula N: The radioresponsiveness of melanoma. Int J Radiat Oncol Biol Phys 1982, 8:1131–1134.

    PubMed  CAS  Google Scholar 

  25. Overgaard J, von der Maase H, Overgaard M: A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. Int J Radiat Oncol Biol Phys 1985, 11:1837–1839.

    PubMed  CAS  Google Scholar 

  26. Leksell L: The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951, 102:316–319.

    PubMed  CAS  Google Scholar 

  27. Leksell DG: Stereotactic radiosurgery. Present status and future trends. Neurol Res 1987, 9:60–68.

    PubMed  CAS  Google Scholar 

  28. Grob JJ, Regis J, Laurans R, et al.: Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancerologie Cutanee. Eur J Cancer 1998, 34:1187–1192.

    Article  PubMed  CAS  Google Scholar 

  29. Gonzalez-Martinez J, Hernandez L, Zamorano L, et al.: Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 2002, 97:494–498.

    PubMed  Google Scholar 

  30. Noel G, Simon JM, Valery CA, et al.: Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002, 79:245–255.

    Article  PubMed  Google Scholar 

  31. Herfarth KK, Izwekowa O, Thilmann C, et al.: Linac-based radiosurgery of cerebral melanoma metastases. Analysis of 122 metastases treated in 64 patients. Strahlenther Onkol 2003, 179:366–371.

    PubMed  Google Scholar 

  32. Radbill AE, Fiveash JF, Falkenberg ET, et al.: Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004, 101:825–833.

    Article  PubMed  Google Scholar 

  33. Selek U, Chang EL, Hassenbusch SJ III, et al.: Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004, 59:1097–1106.

    Article  PubMed  Google Scholar 

  34. Stone A, Cooper J, Koenig KL, et al.: A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest 2004, 22:492–497.

    Article  PubMed  Google Scholar 

  35. Ulm AJ, Friedman WA, Bova FJ, et al.: Linear accelerator radiosurgery in the treatment of brain metastases. Neurosurgery 2004, 55:1076–1085.

    Article  PubMed  Google Scholar 

  36. Wowra B, Muacevic A, Jess-Hempen A, Tonn JC: Safety and efficacy of outpatient gamma knife radiosurgery for multiple cerebral metastases. Expert Rev Neurother 2004, 4:673–679.

    Article  PubMed  Google Scholar 

  37. Mindermann T: Tumor recurrence and survival following gamma knife surgery for brain metastases. J Neurosurg 2005, 102(Suppl):287–288.

    PubMed  Google Scholar 

  38. Gaudy-Marqueste C, Regis JM, Muracciole X, et al.: Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: A series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65:809–816.

    PubMed  Google Scholar 

  39. Wronski M, Arbit E: Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients. J Neurosurg 2000, 93:9–18.

    PubMed  CAS  Google Scholar 

  40. Koc M, McGregor J, Grecula J, et al.: Gamma knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 2005, 71:307–313.

    Article  PubMed  Google Scholar 

  41. Andrews DW, Scott CB, Sperduto PW, et al.: Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665–1672.

    Article  PubMed  Google Scholar 

  42. Manon R, O’Neill A, Knisely J, et al.: Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E6397). J Clin Oncol 2005, 23:8870–8876.

    Article  PubMed  Google Scholar 

  43. Serrone L, Zeuli M, Sega FM, Cognetti F: Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J Exp Clin Cancer Res 2000, 19:21–34.

    PubMed  CAS  Google Scholar 

  44. Bajetta E, Del Vecchio M, Bernard-Marty C, et al.: Metastatic melanoma: chemotherapy. Semin Oncol 2002, 29:427–445.

    Article  PubMed  CAS  Google Scholar 

  45. Paul MJ, Summers Y, Calvert AH, et al.: Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res 2002, 12:175–178.

    Article  PubMed  CAS  Google Scholar 

  46. Atallah E, Flaherty L: Treatment of metastatic malignant melanoma. Curr Treat Options Oncol 2005, 6:185–193.

    Article  PubMed  Google Scholar 

  47. Esteller M, Herman JG: Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene 2004, 23:1–8.

    Article  PubMed  CAS  Google Scholar 

  48. Middleton MR, Grob JJ, Aaronson N, et al.: Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000, 18:158–166.

    PubMed  CAS  Google Scholar 

  49. Agarwala SS, Kirkwood JM, Gore M, et al.: Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol 2004, 22:2101–2107.

    Article  PubMed  CAS  Google Scholar 

  50. Antoniadou D, Paraskevaidis M, Sarris G, et al.: Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002, 20:3644–3650.

    Article  CAS  Google Scholar 

  51. Margolin K, Atkins B, Thompson A, et al.: Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group. J Cancer Res Clin Oncol 2002, 128:214–218.

    Article  PubMed  CAS  Google Scholar 

  52. Samlowski WE, Watson GA, Wang M, et al.: Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007 109:1855–1862.

    Article  PubMed  Google Scholar 

  53. Majer M, Jensen RL, Shrieve DC, et al. Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer, in press.

  54. Mori Y, Kondziolka D, Flickinger JC, et al.: Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys 1998, 42:581–589.

    Article  PubMed  CAS  Google Scholar 

  55. Lavine SD, Petrovich Z, Cohen-Gadol AA, et al.: Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999, 44:59–64.

    Article  PubMed  CAS  Google Scholar 

  56. Mingione V, Oliveira M, Prasad D, et al.: Gamma surgery for melanoma metastases in the brain. J Neurosurg 2002, 96:544–551.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Melanoma, Renal Cancer and Immunotherapy, Nevada Cancer Institute, One Breakthrough Way, 10441 W. Twain Avenue, Las Vegas, NV, 89135, USA

    Wolfram E. Samlowski MD

Authors
  1. Martin Majer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolfram E. Samlowski MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wolfram E. Samlowski MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Majer, M., Samlowski, W.E. Management of metastatic melanoma patients with brain metastases. Curr Oncol Rep 9, 411–416 (2007). https://doi.org/10.1007/s11912-007-0056-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-007-0056-6

Keywords

Search

Navigation